Home/Filings/4/0001178913-22-002402
4//SEC Filing

Marvin Donald 4

Accession 0001178913-22-002402

CIK 0001534248other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 6:01 AM ET

Size

9.2 KB

Accession

0001178913-22-002402

Insider Transaction Report

Form 4
Period: 2022-03-16
Marvin Donald
Executive VP, CFO & COO
Transactions
  • Purchase

    American Depositary Shares

    2022-03-16$3.25/sh+250$8132,000 total
  • Purchase

    American Depositary Shares

    2022-03-16$3.30/sh+250$8251,750 total
  • Award

    Option to Purchase American Depositary Shares

    2021-11-08+196,875196,875 total
    Exercise: $9.77Exp: 2021-11-08American Depositary Shares (196,875 underlying)
Footnotes (3)
  • [F1]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
  • [F2]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
  • [F3]The options vest and become exercisable over a period of four (4) years, with one quarter (1/4) of the options vesting on November 8, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.

Documents

1 file

Issuer

Chemomab Therapeutics Ltd.

CIK 0001534248

Entity typeother

Related Parties

1
  • filerCIK 0001891264

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:01 AM ET
Size
9.2 KB